Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

August 4, 2016August 4, 2016

Sunovion Applies for FDA Approval of SUN-101 and eFlow as Long-term COPD Treatment

COPD

Sunovion Pharmaceuticals has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA), seeking approval of its SUN-101/eFlow technology as a long-term maintenance treatment of airflow obstruction in adult ... Read more

August 1, 2016August 1, 2016

COPD Patients Underuse Pulmonary Rehab, Study Shows

COPD, News

New research conducted by The University of Texas Medical Branch at Galveston suggests that pulmonary rehabilitation (PR) therapy among older adults with chronic obstructive pulmonary disease (COPD) is underutilized – despite the ... Read more

July 29, 2016July 29, 2016

US DOD Grants $11.5M to Study Lung Diseases in Middle East War Vets

Idiopathic Pulmonary Fibrosis, News

Thanks to $11.5 million in grants from the U.S. Department of Defense, researchers from the National Jewish Health respiratory treatment center in Denver will study why veterans who were deployed to the Middle ... Read more

July 28, 2016July 28, 2016

Therapeutic Targets for Small Cell Lung Cancer Identified by UT Southwestern Medical Center Researchers

Lung Cancer, News

A team of researchers at UT Southwestern Medical Center identified the protein ASCL1 as critical for the development of small cell lung cancer (SCLC); the team also found that the absence of ASCL1 in the lungs ... Read more

July 27, 2016July 27, 2016

AdAlta Goes Public to Speed New Therapies for Lung Fibrosis

Idiopathic Pulmonary Fibrosis, News

AdAlta, a drug company, is looking to raise $10 million with an initial public offering (IPO) on the Australian Securities Exchange. The sum will be used to support trials on AD-114, the company’s lead ... Read more

July 22, 2016July 22, 2016

Older COPD Patients, Opioid Use Could Be Fatal Mix

COPD, News

Recent research suggests that opioid use is associated with increased risk for severe respiratory side effects, including death, among older adults with chronic obstructive pulmonary disease (COPD). The study, “Incident opioid drug use and ... Read more

July 19, 2016July 19, 2016

Echocardiography Detects Lung Diseases of Premature Infants at Early Stages in Newborn Mice

News, Pulmonary Hypertension

Two common lung diseases in premature infants, bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH), might be detected by echocardiography at an earlier point than previously thought, reported researchers at Baylor College of ... Read more

July 18, 2016July 18, 2016

Enrollment for Metastatic Non-Small Cell Lung Cancer Trial Cleared by FDA

Lung Cancer, News

BeyondSpring Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) is allowing enrollment in the Phase 1/2 clinical trial to access the company’s drug plinabulin in combination with nivolumab for the treatment of metastatic ... Read more

July 15, 2016July 15, 2016

Positive Preclinical Data on Mifcare’s MFC1040 for PAH Reported

News, Pulmonary Hypertension

Mifcare, a biotechnology company focused on research and development of drug candidates for the treatment of pulmonary hypertension, autoimmune inflammatory diseases and cancer, recently reported encouraging preclinical data for its ... Read more

July 15, 2016July 15, 2016

Center Enrolls First Lung Cancer Patient in Advanced Phase 3 Clinical Trial

Lung Cancer, News

For 40 years, Virginia Cancer Specialists (VCS) has contributed to the campaign against cancer and diseases of the blood by offering advanced technology, treatment and early detection. For residents of ... Read more